LifeMine Therapeutics has closed $263 million in financing to accelerate clinical trials of LIFE-001, a novel immunosuppressant drug discovered through fungal genomics.

Inner Mongolia startup ZhongGu Junchuang is building a 43,000 sq ft mycelium facility in Chengdu, backed by around $22 million in government support.

Vancouver-based Maia Farms raised C$3.75 million to expand production of mushroom and mycelium ingredients targeting functional health applications beyond traditional protein markets

The International Collection of Vesicular Arbuscular Mycorrhizal Fungi (INVAM) at the University of Kansas houses 900 isolates representing 25% of all described AMF species worldwide

As bans on synthetic dyes expand and major brands shift ingredient policies, Chromologics is emerging as a key contender in the growing natural colour market alongside other fermentation-driven competitors.